当前位置:
X-MOL 学术
›
J. Hematol. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Correction to: Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells.
Journal of Hematology & Oncology ( IF 29.5 ) Pub Date : 2019-12-30 , DOI: 10.1186/s13045-019-0792-8 Kai Zhao 1 , Yuxin Zhou 1 , Chen Qiao 1 , Ting Ni 1 , Zhiyu Li 2 , Xiaotang Wang 3 , Qinglong Guo 1 , Na Lu 1 , Libin Wei 1
Journal of Hematology & Oncology ( IF 29.5 ) Pub Date : 2019-12-30 , DOI: 10.1186/s13045-019-0792-8 Kai Zhao 1 , Yuxin Zhou 1 , Chen Qiao 1 , Ting Ni 1 , Zhiyu Li 2 , Xiaotang Wang 3 , Qinglong Guo 1 , Na Lu 1 , Libin Wei 1
Affiliation
The original article [1] contains several errors.
中文翻译:
校正至:Oroxylin A通过SIRT3介导的脱乙酰基促进PTEN介导的MDM2转录负调控,从而稳定p53并抑制wt-p53癌细胞中的糖酵解。
原始文章[1]包含几个错误。
更新日期:2020-04-22
中文翻译:
校正至:Oroxylin A通过SIRT3介导的脱乙酰基促进PTEN介导的MDM2转录负调控,从而稳定p53并抑制wt-p53癌细胞中的糖酵解。
原始文章[1]包含几个错误。